< Back to previous page
Researcher
Evelyne Meyer
- Disciplines:Veterinary microbiology, Veterinary physiology, pathophysiology and biochemistry
Affiliations
- Department of Veterinary and Biosciences (Department)
Member
From1 Oct 2021 → Today - Department of Pharmacology, Toxicology and Biochemistry (Department)
Member
From10 Oct 2005 → 30 Sep 2021 - Department of Comparative physiology and biometrics (Department)
Member
From1 Feb 1999 → 9 Oct 2005 - Department of Bio-analysis (Department)
Member
From1 Jan 1993 → 31 Jan 1999
Projects
1 - 10 of 17
- Spontaneous B-cell lymphoma in dogs: state-of-the-art immunophenotyping and proof of concept on immunotherapeutic targets to benefit canine patientsFrom1 Nov 2023 → TodayFunding: FWO Strategic Basic Research Grant
- Exploring co-encapsulation of antihistamines and immune checkpoint siRNAs in lipid nanoparticles for cancer immunotherapy.From1 Oct 2023 → TodayFunding: BOF - doctoral mandates
- Triple Negative Breast Cancer, Immunotherapy, Tumor microenvironment, Patient selection, Cancer Associated Fibroblasts, Preclinical ModelsFrom1 Dec 2022 → TodayFunding: FWO research project (including WEAVE projects)
- Spontaneous B cell lymphoma in dogs: state-of-the-art immunophenotyping and proof-of-concept on immunotherapeutic targets to benefit canine patientsFrom14 Nov 2022 → 31 Oct 2023Funding: BOF - doctoral mandates
- Cofunding core facility - Flow cytometryFrom1 Nov 2022 → TodayFunding: BOF - research organisations
- Engineered lysines as innovative antimicrobial strategy for the treatment of coliform mastitisFrom1 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- A pipeline for phage lysins targeting multidrug-resistant Staphylococcus pseudintermedius in canine pyoderma and bacterial otitis externaFrom15 Oct 2022 → TodayFunding: IOF - technology validation in lab
- Modular high-end mass spectrometer for ultrasensitive quantification and imaging of small organic molecules in cross-health research - MSsmall-XHFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- Chitinase 3-like 1 as novel immunotherapeutic target in triple-negative breast cancerFrom1 Oct 2021 → TodayFunding: FWO junior postdoctoral fellowship
- RT 20/4 ALTERTOX - Towards risk assessment of Alternaria mycotoxins: comparative in vitro toxicity, and in vivo toxicokinetics in pigs as surrogate animal model for humansFrom1 Sep 2020 → 31 Aug 2022Funding: Ministery of Social Affairs, Public Health and Environment